SYMBOL:

    Up to 100 tickers separated by a space .....Watch Post-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
Company Search   Charts   Research   Earnings   Ratings   Shareholders

Company Web Site
NQNM: (DRTX : $9.01)
$157 million Market Cap at May 8, 2024
Biomedics SubIndustry up .00% / Health Industry up .00% Today
Research Report Earnings Snapshot - Last 08/07/18
Fact Sheet
Financial Statements
Peer Comparison
Annual Reports


Focus is Phase 3 clinical trials with lead product candidate, dalbavancin, for the treatment of patients with acute bacterial skin and skin structure infections, or abSSSI. IPO at $9 July 18, 2012. Raised $67.5 million, selling 7.5 million shares, 44% of the outstanding. Lead Manager: Banc of America.

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Preferred DRTX $9.01 $ 0 $8.93 $9.5999 175,474 $6.65 $10.63 17,240
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $0
Preferred Stock $155,336
Total $155,336

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex